Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Introgen Therapeutics Inc


Ticker Delisted

Company Profile for Introgen Therapeutics Inc (IGU)

Introgen Therapeutics, Inc. develops gene therapy products for the treatment of cancer. The Company's lead product candidate combines the p53 gene, a tumor suppressor gene, with a gene delivery system that it has developed and tested. Introgen is developing cancer therapies which are based on restoring normal cellular function through gene therapy.

Contact Information

Introgen Therapeutics Inc

301 Congress Avenue
Suite 1850
Austin, TX 78701
United States
Phone: 1-512-708-9310
Fax: 1-512-708-9311

Key Executives for Introgen Therapeutics Inc (IGU)

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil